LS Investment Advisors LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 17.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,685 shares of the medical research company’s stock after buying an additional 1,434 shares during the period. LS Investment Advisors LLC’s holdings in Agilent Technologies were worth $574,000 as of its most recent filing with the SEC.
Other large investors have also recently modified their holdings of the company. Garde Capital Inc. increased its stake in shares of Agilent Technologies by 4.2% in the fourth quarter. Garde Capital Inc. now owns 13,341 shares of the medical research company’s stock worth $608,000 after buying an additional 539 shares during the period. Kentucky Retirement Systems purchased a new stake in shares of Agilent Technologies during the fourth quarter worth $1,072,000. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Agilent Technologies during the fourth quarter worth $478,000. Chevy Chase Trust Holdings Inc. increased its stake in shares of Agilent Technologies by 2.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 280,055 shares of the medical research company’s stock worth $14,807,000 after buying an additional 6,577 shares during the period. Finally, CENTRAL TRUST Co increased its stake in shares of Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock worth $158,000 after buying an additional 398 shares during the period.
Agilent Technologies, Inc. (NYSE A) opened at 59.72 on Thursday. The stock has a 50 day moving average price of $60.06 and a 200 day moving average price of $54.77. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $61.84. The company has a market cap of $19.19 billion, a PE ratio of 33.57 and a beta of 1.30.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.10. The business had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.44 earnings per share. Equities analysts forecast that Agilent Technologies, Inc. will post $2.23 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Monday, July 3rd were paid a $0.132 dividend. This represents a $0.53 annualized dividend and a dividend yield of 0.88%. The ex-dividend date was Thursday, June 29th. Agilent Technologies’s dividend payout ratio (DPR) is currently 29.78%.
ILLEGAL ACTIVITY NOTICE: This story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.com-unik.info/2017/07/27/agilent-technologies-inc-a-shares-bought-by-ls-investment-advisors-llc.html.
A number of research analysts recently commented on A shares. Deutsche Bank AG restated a “buy” rating and set a $58.00 price objective (up from $56.00) on shares of Agilent Technologies in a research note on Sunday, April 2nd. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price objective for the company in a research note on Tuesday, May 16th. Cowen and Company upped their price objective on Agilent Technologies from $53.00 to $62.00 and gave the stock a “market perform” rating in a research note on Tuesday, May 23rd. Jefferies Group LLC upped their price objective on Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a research note on Tuesday, May 23rd. Finally, Robert W. Baird upped their price objective on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 24th. Two analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $60.12.
In related news, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $60.60, for a total value of $346,026.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Heidi Fields sold 8,625 shares of the business’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $59.53, for a total value of $513,446.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 150,119 shares of company stock valued at $8,823,719.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.